Colorectal cancer (CRC) remains one of the most formidable challenges in oncolog...
A groundbreaking randomized controlled trial has emerged from the intersection o...
Adenomyosis and Endometrial Cancer: Untangling the Relationship Between Two Comp...
Intensive athletic training propels the human heart into remarkable adaptations,...
In a groundbreaking advancement that promises to reshape our understanding and t...
Sanofi and Regeneron’s experimental COPD drug, itepekimab, produced mixed result...
In its inaugural worldwide phase 3 results, the PD-1xVEGF bispecific antibody iv...
Nearly all patients with depression who were administered Gilgamesh Pharmaceutic...
The U.S. Food and Drug Administration (FDA) has placed a clinical hold on Rocket...
Phase III progression-free survival data were positive for first-line Braftovi i...
EyePoint has entered the final phase of development for its lead product, Duravy...
Alvotech and UK-based Advanz Pharma sign agreement to commercialise three additi...
Stealth Bio has cut 30% of its workforce as it eyes a resubmission based on disc...
Astellas Pharma has signed an exclusive licensing agreement with Evopoint Biosci...
Daiichi and MSD have voluntarily withdrawn the BLA in the US for their patrituma...
In the dynamic field of advanced manufacturing, the control and understanding of...
